Skip to main content
SpringerLink
Log in

Cardiac Manifestations in the Antiphospholipid Syndrome

  • Chapter
Hughes Syndrome

Abstract

A variety of cardiac manifestations have been found in association with antiphospholipid antibodies (aPL), both in patients with systemic lupus erythematosus (SLE) and with the “primary” antiphospholipid syndrome (APS). They mainly include valvular and coronary artery diseases as well as intracardiac thrombus and cardiomyopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ziporen L, Goldberg I, Arad M, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathogenic findings in deformed heart valves. Lupus 1996; 5: 196–205.

    Article  PubMed  CAS  Google Scholar 

  2. Ford PM, Ford SE, Lillicrap DP. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol 1988; 15: 597–600.

    PubMed  CAS  Google Scholar 

  3. Anderson D, Bell D, Lodge R, Grant E. Recurrent cerebral ischemia and mitral valve vegetation in a patient with lupus anticoagulant. J Rheumatol 1987; 14: 839–841.

    PubMed  CAS  Google Scholar 

  4. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990; 82: 369–375.

    Article  PubMed  CAS  Google Scholar 

  5. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart D. et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541–1544.

    Article  PubMed  CAS  Google Scholar 

  6. Cervera R, Font J, Paré C, Azqueta M, Pérez-Villa F, López-Soto A et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992; 51: 156–159.

    Article  PubMed  CAS  Google Scholar 

  7. Cervera R, Khamashta MA, Font J, Reyes PA, Vianna JL, López-Soto A et al. High prevalence of significant heart valve lesions in patients with the “primary” antiphospholipid syndrome. Lupus 1991; 1: 43–47.

    Article  PubMed  CAS  Google Scholar 

  8. Brenner B, Blumenfeld Z, Markiewicz W, Reisner SA. Cardiac involvement in patients with primary antiphospholipid syndrome. J Am Coll Cardiol 1991; 18: 931–936.

    Article  PubMed  CAS  Google Scholar 

  9. Galve E, Ordi J, Barquinero J, Evangelista A, Vilardell M, Soler-Soler J. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992; 116: 293–298.

    PubMed  CAS  Google Scholar 

  10. Nesher G, Ilani J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: Prevalence, clinical features, and treatment. Semin Arthritis Rheum 1997; 27: 27–35.

    Article  PubMed  CAS  Google Scholar 

  11. Metz D, Jolly D, Graciet-Richard J, Nazeyrollas P, Chabert JP, Maillier B et al. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study. Cardiology 1994; 85: 129–136.

    Article  PubMed  CAS  Google Scholar 

  12. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20: 1127–1134.

    Article  PubMed  CAS  Google Scholar 

  13. Leung W-H, Wong K-L, Lau C-P, Wong C-K, Cheng C-H. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990; 89: 411–419.

    Article  PubMed  CAS  Google Scholar 

  14. Amital H, Langevitz P, Levy Y, Afek A, Goldberg I, Pras M et al. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Clin Exp Rheumatol 1999; 17: 99–102.

    PubMed  CAS  Google Scholar 

  15. Garcia-Torres R, Amigo MC, de la Rossa A, Moron A, Reyes PA. Valvular heart disease in primary antiphospholipid syndrome: clinical and morphological findings. Lupus 1996; 5: 56–61.

    PubMed  CAS  Google Scholar 

  16. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93: 1579–1587.

    Article  PubMed  CAS  Google Scholar 

  17. Asherson RA, Gibson DG, Evans DW, Baguley E, Hughes GRV. Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions and transient ischaemic attacks. Ann Rheum Dis 1988; 47: 947–953.

    Article  PubMed  CAS  Google Scholar 

  18. Font J, Cervera R, Paré C, López-Soto A, Pallarés L, Azqueta M et al. Haemodynamically significant non-infective verrucous endocarditis in a patient with “primary” antiphospholipid syndrome. Br J Rheumatol 1991; 30: 305–307.

    Article  PubMed  CAS  Google Scholar 

  19. Asherson RA, Tikly M, Staub H, Wilmshurst A, Coltart DJ, Khamashta MA et al. Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies. Ann Rheum Dis 1990; 49: 107–108.

    Article  PubMed  CAS  Google Scholar 

  20. Young SM, Fisher M, Sigsbee A, Errichetti A. Cardiogenic brain embolism and lupus anticoagulant. Ann Neurol 1989; 26: 390–392.

    Article  PubMed  CAS  Google Scholar 

  21. D’Alton JG, Preston DN, Bormanis J et al. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985; 16: 512–514.

    Article  PubMed  Google Scholar 

  22. Levine SR, Kim S, Deegan MJ, Welch KMA. Ischemic stroke associated with anticardiolipin antibodies. Stroke 1987; 18: 1101–1106.

    Article  PubMed  CAS  Google Scholar 

  23. The Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischaemia. Stroke 1990; 21: 1268–1273.

    Google Scholar 

  24. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366–374.

    CAS  Google Scholar 

  25. Camps MT, Guil M, Grana MI, de Ramón E. Manifestaciones clínicas y analíticas del síndrome antifosfolípido primario. Med Clin (Barc) 1995; 104: 37–38.

    Google Scholar 

  26. Diaz MN, Becker RC. Anticardiolipin antibodies in patients with ustable angina. Cardiology 1994; 84: 380–384.

    Article  PubMed  CAS  Google Scholar 

  27. Hamsten A, Norberg R, Bjorkholm M, DeFirre U, Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1986; 1: 113–116.

    Article  PubMed  CAS  Google Scholar 

  28. Vaarala O, Mänttäri M, Manninen V, Tenkanen L, Puurunen M, Aho K et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995; 91: 23–27.

    Article  PubMed  CAS  Google Scholar 

  29. Matsuura E, Kobayashi K, Yasuda T, Koike T. Antiphospholipid antibdodies and atherosclerosis. Lupus 1998; 7 (Suppl 2): S135 - S139.

    Article  PubMed  CAS  Google Scholar 

  30. Asherson RA, Mackay KR, Harris EN. Myocardial infarction in a young male with systemic lupus erythematosus, deep vein thrombosis and antibodies to phospholipid. Br Heart J 1986; 56: 190–193.

    Article  PubMed  CAS  Google Scholar 

  31. Staub HL, Harris EN, Khamashta MA et al. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann Rheum Dis 1989; 48: 166–169.

    Article  PubMed  CAS  Google Scholar 

  32. Asherson RA, Harris EN, Gharavi AE, Hughes GRV. Myocardial infarction in SLE and “lupus-like” disease. Arthritis Rheum 1985; 29: 1292–1293.

    Article  Google Scholar 

  33. Bingley PJ, Hoffbrand BI. Antiphospholipid antibody syndrome: a review. J R Soc Med 1987; 80: 445–448.

    PubMed  CAS  Google Scholar 

  34. Hodges JR. Chorea and the lupus anticoagulant. J Neurol Neurosurg Psychiatr 1987; 50: 368–369.

    Article  PubMed  CAS  Google Scholar 

  35. Vermylen J, Blockmans D, Spitz B, Deckmyn H. Thrombosis and immune disorder. Clin Haematol 1986; 15: 393–412.

    PubMed  CAS  Google Scholar 

  36. Waddell CC, Brown JA. The lupus anticoagulant in 14 male patients. JAMA 1982; 248: 2493–2495.

    Article  PubMed  CAS  Google Scholar 

  37. Jungers P, Lioté F, Dautzenberg MD et al. Lupus anticoagulant and thrombosis in systemic lupus erythematosus. Lancet 1984; 1: 574–575.

    Article  PubMed  CAS  Google Scholar 

  38. Harpaz D, Glikson M, Sidi Y, Hod H. Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndrome. Am Heart J 1991; 122: 1492–1495.

    Article  PubMed  CAS  Google Scholar 

  39. Mills TJ, Safford RE, Kazmier FJ. Myocardial infarction, persistent coronary artery thrombosis and lupus anticoagulant. Int J Cardiol 1988; 21: 190–194.

    Article  PubMed  CAS  Google Scholar 

  40. Ghirardello A, Doria A, Ruffatti A, Rigoli AM, Vesco P, Calligaro A et al. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? Ann Rheum Dis 1994; 54: 140–142.

    Article  Google Scholar 

  41. Shaley Y, Green L, Pollak A, Bentwich Z. Myocardial infarction with central retinal artery occlusion in a patient with antinuclear antibody-negative systemic lupus erythematosus. Arthritis Rheum 1985; 85: 1185–1187.

    Article  Google Scholar 

  42. Bick RL, Baker WF. Anticardiolipin antibodies and thrombosis. Hematol Oncol Clin North Am 1992; 6: 1287–1299.

    PubMed  CAS  Google Scholar 

  43. Asherson RA, Chan JKH, Harris EN, Gharavi AE, Hughes GRV. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis 1985; 44: 823–825.

    Article  PubMed  CAS  Google Scholar 

  44. Exner T, Koutts J. Autoimmune cardiolipin-binding antibodies in oral anticoagulant patients. Aust N Z J Med 1988; 18: 669–673.

    Article  PubMed  CAS  Google Scholar 

  45. Shortell CK, Ouriel K, Green RM, Condemi JA, DeWeese JA. Vascular disease in the antiphospholipid syndrome: A comparison with the patient population with atherosclerosis. J Vasc Surg 1992; 15: 158–166.

    Article  PubMed  CAS  Google Scholar 

  46. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303–308.

    PubMed  CAS  Google Scholar 

  47. Asherson RA, Khamashta MA, Baguley E, Oakley CM, Rowell NR, Hughes GRV. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Quart J Med 1989; 73: 1103–1115.

    PubMed  CAS  Google Scholar 

  48. Alarcón-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482–488.

    PubMed  Google Scholar 

  49. Mackworth-Young CG, Loizou S, Walport MJ. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989; 48: 362–367.

    Article  PubMed  CAS  Google Scholar 

  50. Font J, López-Soto A, Cervera R et al. The “primary” antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991; 9: 69–75.

    Article  PubMed  CAS  Google Scholar 

  51. Martínez-Vazquez C, Albo C, Ribera A, Bordón J, Rodriguez A, Sopena B et al. Sindrome antifosfolfpido primario. Aspectos clinico-evolutivos de 24 casos. Rev Clin Esp 1994; 194: 164–169.

    PubMed  Google Scholar 

  52. Cervera R, Font J, López-Soto A et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus. Prospective analysis of a series of 100 patients. Ann Rheum Dis 1990; 49: 109–113.

    Article  PubMed  CAS  Google Scholar 

  53. Alarcón-Segovia D, Delezé M, Oria CV, Sanchez-Guerrero J, Gómez-Pacheco L, Cabiedes J et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68: 353–374.

    Google Scholar 

  54. Sletnes KE, Larsen EW, Stokland O, Wisloff F. Antiphospholipid antibodies detected as anticephalin and anticardiolipin antibodies in patients with acute myocardial infarction: immunological response to myocardial necrosis? Thromb Res 1990; 59: 675–680.

    Article  PubMed  CAS  Google Scholar 

  55. Klemp P, Cooper R, Jordan E, Przybojewski N. Anti-cardiolipin antibodies in ischaemic heart disease. Clin Exp Immunol 1988; 74: 254–257.

    PubMed  CAS  Google Scholar 

  56. De Caterina R, D’Ascanio A, Mazzone A, Gazzaetti P, Bernini W, Neri R et al. Prevalence of anticardiolipin antibodies in coronary artery disease. Am J Cardiol 1989; 65: 922–923.

    Article  Google Scholar 

  57. Sletnes KE, Smith P, Abdelnoor M, Arnesen H, Wisloff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet 1992; 339: 451–453.

    Article  PubMed  CAS  Google Scholar 

  58. Cortellaro M, Cofrancesco E, Boschetti C. Cardiolipin antibodies in survivors of myocardial infarction. Lancet 1993; 342: 192.

    Article  PubMed  CAS  Google Scholar 

  59. Edwards T, Thomas RD, McHugh NJ. Anticardiolipin antibodies in ischaemic heart disease. Lancet 1993; 342: 989.

    Article  PubMed  CAS  Google Scholar 

  60. Phadke KV, Phillips RA, Clarke DT, Jones M, Naish P, Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J 1993; 69: 391–394.

    Article  PubMed  CAS  Google Scholar 

  61. Yilmaz E, Adalet K, Yilmaz G, Badur S, Erzengin F, Koylan N et al. Importance of serum anticardiolipin antibody levels in coronary heart disease. Clin Cardiol 1994; 17: 117–121.

    Article  PubMed  CAS  Google Scholar 

  62. Raghavan C, Ditchfield J, Taylor RJ, Haeney MR, Barnes PC. Influence of anticardiolipin antibodies on immediate patient outcome after myocadial infarction. J Clin Pathol 1993; 46: 1113–1115.

    Article  PubMed  CAS  Google Scholar 

  63. Gavaghan TP, Krilis SA, Daggard GE, Baron DE, Hickie JB, Chesterman CN. Anticardiolipin antibodies and occlusion of coronary artery bypass grafts. Lancet 1987; 2: 977–978.

    Article  PubMed  CAS  Google Scholar 

  64. Bick RL. The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion, and controversy. Am J Clin Pathol 1993; 100: 477–480.

    PubMed  CAS  Google Scholar 

  65. Vaarala O. Antiphospholipid antibodies and myocardial infarction. Lupus 1998; 7 (Suppl 2): S132 - S134.

    Article  PubMed  CAS  Google Scholar 

  66. George J, Afek A, Gilburg B, Blank M, Levy Y, Aron-Maor A et al. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with ß-2-glycoprotein I. Circulation 1998; 98: 1108–1115.

    Article  PubMed  CAS  Google Scholar 

  67. Asherson RA, Cervera R. Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation 1991; 84: 920–923.

    Article  PubMed  CAS  Google Scholar 

  68. Asherson RA, Cervera R. Antiphospholipid and the heart: reply. Circulation 1992; 85: 2332.

    Google Scholar 

  69. Morton KE, Gavaghan TP, Krilis SA, Daggard GE, Baron DW, Hickie JB et al. Coronary artery bypass graft failure: an autoimmune phenomenon? Lancet 1986; 2: 1353–1356.

    Article  PubMed  CAS  Google Scholar 

  70. Gavaghan TP, Krilis SA, Daggard GE, Baron DE, Hickie JB, Chesterman CN. Anticardiolipin antibodies and occlusion of coronary bypass grafts. Lancet 1987; 2: 977–978.

    Article  PubMed  CAS  Google Scholar 

  71. Eber B, Schumacher M, Auer-Grumbach P, Toplak H, Klein W. Increased IgM anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992; 69: 1255–1258.

    Article  PubMed  CAS  Google Scholar 

  72. Lubbe WF, Asherson RA. Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant. Arthritis Rheum 1988; 31: 1453–1454.

    Article  PubMed  CAS  Google Scholar 

  73. Leventhal LJ, Borofsky MA, Bergey PD, Schumacher HR Jr. Antiphospholipid antibody syndrome with right atrial thrombosis mimicking an atrial myxoma. Am J Med 1989; 87: 111–113.

    Article  PubMed  CAS  Google Scholar 

  74. Brown JH, Doherty CC, Allan DC, Morton P. Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus. Br Med J 1989; 298: 525.

    Article  CAS  Google Scholar 

  75. Murphy JJ, Leach IA. Findings at necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J 1989; 62: 61–64.

    Article  PubMed  CAS  Google Scholar 

  76. Kattwinkel N, Villanueva AG, Labib SB, Aretz T, Walek JW, Burns DL et al. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann Intern Med 1992; 116: 974–976.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Font
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Cervera
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, Lambeth Palace Road, SE1 7EH, London, UK

    M. A. Khamashta MD, MRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag London

About this chapter

Cite this chapter

Font, J., Cervera, R. (2000). Cardiac Manifestations in the Antiphospholipid Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/978-1-4471-3666-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3666-8_4

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-232-7

  • Online ISBN: 978-1-4471-3666-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation